The AI Physical Therapy Boom: What Sword Health and Hinge Health Aren’t Telling You
Two companies have turned “physical therapy in an app” into a combined multi-billion-dollar industry β Hinge Health went public on the NYSE in 2025 and now trades at a market cap north of $4 billion, while Sword Health was recently valued around $4 billion in a private funding round. Here’s the part that doesn’t make the investor pitch decks: an independent, non-vendor evaluation found these AI-driven platforms produce clinically meaningful improvements comparable to in-person physical therapy β genuinely good news β but most of the specific outcome numbers you’ll see cited come from the companies’ own research, no independent study has ever compared these two giants head-to-head, and physical therapy professionals have directly and publicly questioned whether what you’re getting is actually “physical therapy” at all. This article covers both halves of that story honestly: the real independent evidence, and the real, documented gaps in it.
Educational only. Not medical advice. If you have musculoskeletal pain, particularly if it’s severe, persistent, or accompanied by other symptoms, consult a licensed healthcare provider to determine the most appropriate care option for your specific condition.
Table of Contents
- Why This Market Exists β and Why It’s Now Worth Billions
- Follow the Money First
- How These Platforms Actually Work
- The Independent Evidence: What an Outside, Non-Vendor Evaluator Found
- The Company-Specific Research β Real, But Worth Reading Carefully
- No Head-to-Head Comparison Exists
- The Professional Skepticism Worth Taking Seriously
- What This Category Is Good At β and What It Likely Isn’t
- Quick Comparison
- Questions to Ask About Any Virtual PT Platform
- Who This Is Actually Right For
- FAQs
- The Bottom Line
π Why This Market Exists β and Why It’s Now Worth Billions
The scale of the underlying problem explains why investors have poured money into this category. An estimated 40% of U.S. adults have a musculoskeletal (MSK) condition β chronic back, knee, hip, or shoulder pain β but only about 9% ever actually see a physical therapist for it, according to figures disclosed in Hinge Health’s own SEC filings. Musculoskeletal conditions collectively cost the U.S. healthcare system roughly $1.3 trillion annually. The global digital MSK care market was valued at $4.4 billion in 2024, is estimated at $6.0 billion in 2026, and is projected to reach $11.6 billion by 2030 β real, substantial growth reflecting real, substantial unmet need. That underlying gap between people who need care and people who get it is genuine, which is worth keeping in mind: the demand these apps are addressing is real, even before evaluating how well they address it.
π° Follow the Money First
It’s worth understanding the financial trajectory of the two biggest players here, because it tells its own story about how the market’s confidence in this category has evolved. Hinge Health was privately valued at $6.2 billion in 2021, during the peak of pandemic-era digital health enthusiasm. When it actually went public in May 2025, it priced its IPO at $32 per share β an initial public valuation of just $2.6 billion, less than half its earlier private valuation. That’s a real, meaningful correction, not a rounding error.
βοΈ How These Platforms Actually Work
Both platforms combine a few core components: AI-powered motion tracking (via smartphone camera or dedicated hardware) that monitors exercise form in real time, a structured exercise program targeting a specific condition, and some level of oversight from a licensed physical therapist or health coach. Hinge Health has gone further than most competitors on the hardware side, developing a proprietary FDA-cleared wearable device called Enso, used alongside its software platform β a genuine, verifiable regulatory clearance worth noting specifically, distinct from the platform-level clinical outcome claims discussed below. Sword Health describes its model as “Human Clinicians + AI,” with a Doctor of Physical Therapy setting the clinical plan and AI extending day-to-day touchpoints between sessions.
One practical detail shapes who actually encounters this technology: these are overwhelmingly sold to employers and health insurers as a workplace benefit, not marketed directly to individual consumers the way a fitness app might be. Hinge’s own disclosed client list β nearly half of the Fortune 100 β reflects this B2B2C model directly.
π¬ The Independent Evidence: What an Outside, Non-Vendor Evaluator Actually Found
The most significant genuinely independent evaluation of this category comes from the Peterson Health Technology Institute (PHTI), a nonprofit research organization that evaluates digital health technologies without vendor funding. In a 2024 report examining digital musculoskeletal care solutions β including Hinge Health, Sword Health, Kaia Health, Omada Health, RecoveryOne, Vori Health, DarioHealth, and Limber Health β PHTI concluded that these PT-guided digital solutions “improve patient outcomes on pain and function comparably to in-person physical therapy, with a net decrease in spending,” and stated that for many conditions, they “may be reasonably substituted for in-person therapy.”
π The Company-Specific Research β Real, But Worth Reading Carefully
Beyond PHTI’s independent evaluation, individual companies point to their own published research, and it’s worth being precise about what that research actually is.
Sword Health cites several real, peer-reviewed studies with verifiable publication details: a 2022 study in the Journal of Medical Internet Research examining racial and ethnic differences in outcomes of its 12-week digital rehabilitation program (DOI: 10.2196/41306), a 2023 study in JMIR Rehabilitation and Assistive Technologies on managing musculoskeletal pain in older adults through the platform (DOI: 10.2196/49673), and a 2023 study in npj Digital Medicine β a Nature-family journal β examining the platform’s potential to address healthcare inequities related to socioeconomic status (DOI: 10.1038/s41746-023-00936-2). These are genuine, findable, peer-reviewed publications, which is more than can be said for many “AI health app” claims covered elsewhere on this site. The important caveat: these studies are company-affiliated research, examining the company’s own platform, which doesn’t make the findings false, but does mean they carry the same “who funded this” consideration that applies to any industry-affiliated research β the same caveat we apply to company-funded studies in our look at AI symptom checkers.
Hinge Health reports a broader disclosure of 19 peer-reviewed articles and studies overall, and cites a 2020 cohort of 10,000 members with chronic knee or back pain showing a 68% average pain improvement after 12 weeks, along with reported reductions in depression and anxiety symptoms and approximately $2,400 in employer healthcare savings per engaged member. These figures come through Hinge’s own disclosures and internally referenced research rather than an independent, head-to-head comparison β worth noting plainly, since a 68% improvement figure sounds precise but reflects the company’s own reporting of its own cohort, not an outside audit.
βοΈ No Head-to-Head Comparison Exists β Despite Billions Riding on the Answer
Here’s a detail worth sitting with, given how much capital markets have riding on which of these companies “wins”: no peer-reviewed trial has directly compared Hinge Health, Sword Health, and other platforms against each other. Each company’s research generally compares its own program against usual care or a historical baseline β not against a competing digital platform. This means that while the PHTI report supports the category broadly, comparing specific numbers between companies (Sword’s studies vs. Hinge’s 68% figure, for instance) isn’t a valid way to determine which platform is “better,” since the studies weren’t designed to allow that comparison in the first place. Investor analyses and competitive comparisons abound β but a genuinely independent, randomized, head-to-head clinical trial between the two market leaders, despite their combined multi-billion-dollar valuations, does not yet exist.
π£οΈ The Professional Skepticism Worth Taking Seriously
Independent commentary from within the physical therapy profession has raised a pointed, legitimate critique that’s worth including directly rather than glossing over. One physical therapy industry analysis put it bluntly: “I don’t think Hinge and Sword are providing physical therapy. They’re providing technology-enabled exercise programs with varying degrees of clinical oversight, calling it something other than PT, and letting third-party administrators tell employers they now have ‘virtual physical therapy.’ That’s not the same thing.” The same analysis raised a direct methodological concern about the underlying evidence base: “Most studies have been conducted or funded by the vendors themselves,” and questioned whether the patient populations studied fully represent the range of conditions and complexity a traditional in-person PT practice would handle.
π― What This Category Is Good At β and What It Likely Isn’t
Based on the evidence above, a reasonable synthesis: for relatively straightforward musculoskeletal pain β common back, knee, hip, or shoulder issues without major complicating factors β the independent PHTI evaluation supports these platforms as a legitimate, cost-effective option with outcomes comparable to standard in-person care. For complex cases requiring hands-on manual therapy, nuanced case management, or conditions that don’t fit neatly into a structured exercise program, the professional critique’s distinction between “technology-enabled exercise” and comprehensive physical therapy is a reasonable one to take seriously β these platforms aren’t designed or evidenced for that level of complexity, and none of the research cited above claims otherwise.
π Quick Comparison
| Hinge Health | Sword Health | |
|---|---|---|
| Status | Public (NYSE: HNGE, IPO May 2025) | Private, ~$4B 2025 valuation |
| Market cap / valuation (2026) | ~$4.3Bβ$7.3B | ~$4B (private) |
| Hardware | FDA-cleared Enso wearable | Software + DPT-set clinical plan |
| Peer-reviewed studies | 19 disclosed articles/studies overall | 3 verified, findable studies (JMIR, JMIR Rehab, npj Digital Medicine) |
| Headline outcome figure | 68% pain improvement (self-disclosed, 2020 cohort, n=10,000) | Study-specific findings per publication |
| Independent head-to-head trial | Does not exist for either platform | |
| Independent category evaluation | PHTI (2024): comparable to in-person PT for many conditions | |
β Questions to Ask About Any Virtual PT Platform
- Is this being offered as a replacement for traditional PT, or a first-line option for straightforward musculoskeletal pain? The independent evidence supports the latter use case far more clearly than the former.
- How much actual licensed-clinician contact is included, versus AI-guided self-exercise? This varies significantly across platforms and even across programs within the same company.
- Is the specific outcome data you’re being shown from an independent source (like PHTI), or from the company’s own disclosed research? Both can be legitimate, but they deserve different levels of scrutiny.
- Does your condition fit the relatively straightforward MSK pain profile these platforms are best evidenced for, or is it more complex? If you have a complicating diagnosis, ask directly whether the platform’s clinical oversight is sufficient, or whether in-person care is more appropriate.
- How is this actually being offered to you β direct-to-consumer, or through an employer/insurer benefit? Most of these platforms operate on the latter model, which affects both cost and how much choice you have between competing options β the same “who’s actually paying for this benefit” question worth asking about our corporate meditation pod coverage.
π Who This Is Actually Right For
If you have common, relatively straightforward musculoskeletal pain β the kind of back, knee, hip, or shoulder issues that make up the bulk of employer health claims in this category β and you have access to one of these platforms through your employer or insurer, the independent PHTI evaluation gives real, credible support for trying it as a legitimate first option, with cost and convenience advantages over in-person care for many people.
If you have a more complex condition, a history of failed conservative treatment, or a diagnosis that would benefit from hands-on manual therapy and nuanced clinical judgment, the professional critique above is worth taking seriously β a conversation with a licensed, in-person physical therapist about whether a digital-first approach is appropriate for your specific situation is the more evidence-consistent path, rather than assuming any MSK pain automatically fits a virtual, AI-guided program equally well.
βοΈ Written by Maryam
Maryam researches and writes about health technology and wellness trends at Future Wellness & Tech, covering wearables, apps, and digital health tools. Content is reviewed for accuracy before publishing.
β Frequently Asked Questions
Do AI virtual physical therapy apps actually work as well as in-person PT?
An independent 2024 evaluation by the Peterson Health Technology Institute found that digital MSK platforms like Hinge Health and Sword Health produce clinically meaningful improvements in pain and function comparable to in-person physical therapy for many conditions, with reduced healthcare spending. This applies most clearly to straightforward musculoskeletal pain rather than complex cases.
Is Sword Health or Hinge Health better?
No independent, peer-reviewed trial has directly compared the two platforms, so claims comparing their specific outcome numbers aren’t a valid basis for choosing between them. Each company’s published research compares its own program to usual care, not to a competing platform. Hinge Health is publicly traded (NYSE: HNGE) with a multi-billion-dollar market cap; Sword Health remains private with a similar private valuation.
Can I sign up for these platforms directly, or do I need it through my employer?
Most access to these platforms comes through an employer benefit or health insurance plan rather than a direct-to-consumer subscription, since they’re primarily sold to employers and health plans as a musculoskeletal care benefit β Hinge Health alone reports contracts covering more than 20 million lives through employer and health plan partnerships.
Are these apps a replacement for a physical therapist?
For relatively straightforward musculoskeletal pain, independent evidence supports comparable outcomes to in-person care. For complex conditions requiring hands-on manual therapy or nuanced clinical judgment, physical therapy professionals have raised legitimate concerns that these platforms function more as technology-enabled exercise programs than comprehensive physical therapy, and in-person care remains the more evidence-consistent choice.
π Sources & References
- Peterson Health Technology Institute, “Digital MSK Solutions” evaluation, as reported in Fierce Healthcare, “Digital physical therapy solutions can improve patient outcomes, reduce healthcare spending, report finds”
- Scheer, J., et al., “Racial and Ethnic Differences in Outcomes of a 12-Week Digital Rehabilitation Program for Musculoskeletal Pain: Prospective Longitudinal Cohort Study,” Journal of Medical Internet Research, 2022;24(10):e41306
- Areias, A.C., et al., “Managing Musculoskeletal Pain in Older Adults Through a Digital Care Solution: Secondary Analysis of a Prospective Clinical Study,” JMIR Rehabilitation and Assistive Technologies, 2023;10:e49673
- Dias Correia, F., et al., “The Potential of a Multimodal Digital Care Program in Addressing Healthcare Inequities in Musculoskeletal Pain Management,” npj Digital Medicine, 2023;6:121
- Physical Therapy Substack, “Part II: 2026 Physical Therapy Predictions: The Year We Find Out What We’re Made Of” (independent professional critique)
- Fierce Healthcare, “Hinge Health shares jump 17% in stock market debut, setting the stage for digital health IPO revival”
- Fierce Healthcare, “Hinge Health files to go public, signaling potential IPO revival”
- Sacra, “Hinge Health revenue, funding & growth rate”
- Healthcare.digital, “Digital Musculoskeletal Care Market: Transatlantic Champions v. European Platform Innovations”
- Grand View Research, “Digital Health For Musculoskeletal Care Market Report, 2025-2030”
- MEXC Blog, “Sword Health IPO 2026: Valuation, Competitors & How To Invest”
Verification notes: The Peterson Health Technology Institute evaluation is presented as the primary independent evidence source in this article, distinct from company-disclosed research, and its more critical parallel report on digital diabetes tools is cited to establish PHTI’s credibility as a non-rubber-stamp evaluator. Sword Health’s cited studies were independently verified as real, findable, peer-reviewed publications with working DOIs, though they remain company-affiliated research examining the company’s own platform. Hinge Health’s 68% pain improvement figure and related statistics are explicitly labeled as company-disclosed rather than independently audited. Market cap, IPO pricing, valuation history, and revenue figures for both companies were independently cross-checked across multiple financial and trade-press sources (Fierce Healthcare, Sacra, Grand View Research, MEXC) rather than taken from either company’s own promotional materials. The professional critique quoted is presented as one named, independent perspective from within the physical therapy field, not as a consensus position of the entire profession.
π‘ The Bottom Line
This is one of the more genuinely evidence-supported categories in digital health β a real independent evaluation (PHTI) found comparable clinical outcomes to in-person care for many conditions, at least one major platform (Sword Health) has real, peer-reviewed, journal-published research behind specific claims, and Hinge Health has a genuinely FDA-cleared hardware device, not just software claims. But the billions of dollars now riding on this market don’t change the honest gaps in the underlying evidence: most of the detailed outcome numbers you’ll see cited come from the companies themselves, no independent trial has compared these platforms head-to-head despite years of direct competition, and physical therapy professionals have a legitimate point that “AI-guided exercise program” and “comprehensive physical therapy” aren’t automatically the same thing, especially for complex cases. Both the genuine promise and the genuine limitation are real, and a multi-billion-dollar valuation doesn’t resolve either one.
